Soluble MICA and anti-MICA Antibodies as Biomarkers of Nasopharyngeal Carcinoma Disease-Reference-Cited by-同舟云学术

Soluble MICA and anti-MICA Antibodies as Biomarkers of Nasopharyngeal Carcinoma Disease

Published:2019-12-09 Issue:5 Volume:49 Page:498-509
ISSN:0882-0139
Container-title:Immunological Investigations
language:en
Short-container-title:Immunological Investigations

Author:

Ben Chaaben Arij¹²,Ouni Nesrine¹³^ORCID,Douik Hayet¹,Ayari Fayza¹,Abaza Hajer¹,Mamoghli Tesnim¹,Harzallah Latifa¹,Fortier Cathy²,Boukouaci Wahid²,Krishnamoorthy Rajagopal⁴,Charron Dominique²,Gara Sonia¹,Guemira Fethi¹,Tamouza Ryad⁵⁶⁷

Affiliation:

1. Clinical Biology Department, Salah Azaiz Institut, Tunis, Tunisia

2. Immunology and Histocompatibility Department, CIH-HOG, AP-HP/GHU-Nord, IUH and INSERM, U940, Saint-Louis Hospital, Paris, France

3. Faculty of Mathematics, Physics and Natural Sciences, University of Tunis El Manar, Tunis, Tunisia

4. INSERM U763, Robert Debré Hospital, Paris, France

5. INSERM, U955, Translational Psychiatry, Paris-East University, Creteil, France

6. AP-HP, DHU PePSY, Department of Psychiatry, Hôpital Henri Mondor, Université Paris-Est-Creteil, Creteil, France

7. Fondation FondaMental, Creteil F94000, France

Funder

INSERM UMRS 1160 team and Assistance Public des Hopitaux de Paris (AP-HP) and by the French-Tunisian (Tamouza-Guemira) bilateral co-operation

Publisher

Informa UK Limited

Subject

General Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/08820139.2019.1690506

Reference48 articles.

1. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions

2. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample

3. Le carcinome nasopharyngé en Afrique du Nord et dans le Sud-Est asiatique : entre similitude et différence

4. Polymorphisme génétique du cytochrome P450 2E1 et le risque du cancer du nasopharynx

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review);Oncology Reports;2024-08-14

2. Letter from the Editor: 2022;Immunological Investigations;2022-11-17

3. Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives;Frontiers in Oncology;2022-03-02

4. The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy;Vaccines;2021-11-19

5. Genetic variants in NKG2D axis and susceptibility to Epstein–Barr virus-induced nasopharyngeal carcinoma;Journal of Cancer Research and Clinical Oncology;2021-01-03